Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
by IFA Online | Oct 14, 2023 | Financial News
Recent Comments